NBIX compared with INCY: revenue, margins and what each company keeps, and the suppliers and customers both name

NBIXNeurocrine Biosciences Inc

Mkt capRevenueRevenue

INCYIncyte Corp

Mkt capRevenueRevenue

Compare

NBIXNeurocrine Biosciences Inc

INCYIncyte Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

NBIXwithINCY

×0.33co-movement · INCY on NBIX · 500d

r 0.33scale to r 0.75

Shared co-movers1with NBIXwith INCY

INDVIndivior Pharmaceuticals, Inc.r 0.32r 0.37

NBIX, solidINCY, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

NBIXNeurocrine Biosciences Inc

145.87· pre 155.19· delayed

Mkt cap$14.7BRevenue$1.1BQ3 FY26Revenue$2.9BFY25

INCYIncyte Corp

120.04· pre 120.07· delayed

Pre-marketNov 3 '26delayed

Mkt cap$24.5BRevenue$1.6BQ3 FY26Revenue$5.1BFY25

Compare

Pre-marketNov 3 '26delayed

NBIXNeurocrine Biosciences Inc

INCYIncyte Corp

145.87pre 155.19delayed

Price

120.04pre 120.07delayed

$14.7B

Mkt cap

$24.5B

Q3 FY26$1.1B

Revenue

$1.6BQ3 FY26

FY25$2.9B

Revenue

$5.1BFY25

NBIX145.87vsINCY120.04Pre-marketNov 3 '26delayed